GLAXOSMITHKLINE AUSTRALIA PTY LTD Litigation and court case watch
Litigation alerts: hidden
- Courts and tribunals in every state and territory
- Checked every day, alerts by email
- From US$9 a month, cancel any time
Glaxosmithkline Australia Pty Ltd (ACN 100162481) is an Australian private company registered in 2002. ASIC's company register lists it as registered as at November 2026.
Litigation and court cases: Glaxosmithkline Australia Pty Ltd
Courts and tribunals record companies by their legal name. LitigationWatch looks for GLAXOSMITHKLINE AUSTRALIA PTY LTD (ACN 100 162 481) in matters before the High Court, the Federal Court, the Federal Circuit and Family Court, the Supreme, District, County, Local and Magistrates Courts of every state and territory, and tribunals such as the Fair Work Commission, the Administrative Review Tribunal and each state's civil and administrative tribunal.
When Glaxosmithkline Australia Pty Ltd is named as a party, you get an email with the court, the case and what happened, such as a new filing or a hearing being listed, with a link to the court's record where one is available.
Claims are often brought against a parent company, a subsidiary or a trustee company rather than the business you know. Glaxosmithkline Australia Pty Ltd is associated with 5 companies through majority shareholdings: see them below, or watch them together with Glaxosmithkline Australia Pty Ltd.
Using an AI agent? Tell it: Watch Glaxosmithkline Australia Pty Ltd (ACN 100 162 481) for litigation with litigationwatch.dev.
Agents can add it in one call; see the agent guide.
This page does not list court cases. Nothing on it suggests that Glaxosmithkline Australia Pty Ltd is or has been a party to legal proceedings.
Why watch Glaxosmithkline Australia Pty Ltd for litigation
- Early warning of unpaid debts: a creditor's application to wind a company up is filed in court, often before any other public sign.
- Knowing who you deal with: suppliers, customers, landlords and lenders learn if a company they rely on sues or is sued.
- Due diligence: investors and buyers see new claims, class actions and regulator cases, including during a deal.
- Regulator action: cases brought by ASIC, the ACCC or the tax office can point to compliance problems.
- Your own group: claims are often filed against a subsidiary or trustee company, so watching each entity means none reaches you late.
Key facts
| Item | Recorded |
|---|---|
| Legal name | GLAXOSMITHKLINE AUSTRALIA PTY LTD |
| ACN | 100162481 |
| ABN | 47100162481 |
| Company type | Australian Private Company |
| Status (ASIC register, November 2026) | Registered |
| Status in the 2023 records | Registered |
| Class (ASIC register) | Limited by shares |
| Sub-class (ASIC register) | Proprietary company |
| Former names | Gsk Operations Pty Ltd |
| Current name since | 2002 |
| Registered | 2002 (about 21 years before these records) |
| Current directors | 3 |
| Current secretaries | 2 |
| Shareholders recorded | 1 |
| Share classes | 1 |
| Ultimate holding company | Glaxosmithkline Plc |
| Appointed auditor | Pricewaterhousecoopers |
Associated parties
Following majority shareholdings up to three levels above and below it, Glaxosmithkline Australia Pty Ltd is associated with 5 companies and 76 people.
| Company |
|---|
| Glaxosmithkline Investments Pty Ltd Litigation alerts: hidden Watch |
| Glaxosmithkline Holdings Pty Ltd Litigation alerts: hidden Watch |
| Glaxo Wellcome Australia Pty Ltd Litigation alerts: hidden Watch |
| Wellcome Developments Pty Ltd Litigation alerts: hidden Watch |
| Wellcome Operations Pty Ltd Litigation alerts: hidden Watch |
Board changes by year
Between 2002 and 2022, records show 40 appointments and 31 recorded departures at Glaxosmithkline Australia Pty Ltd. The busiest year was 2002, with 10 changes. For 4 former roles the year of leaving is not recorded.
| Year | Appointed | Left |
|---|---|---|
| 2022 | 1 | 0 |
| 2021 | 2 | 0 |
| 2019 | 2 | 2 |
| 2018 | 2 | 2 |
| 2017 | 1 | 0 |
| 2016 | 2 | 2 |
| 2015 | 2 | 1 |
| 2014 | 1 | 3 |
| 2013 | 0 | 1 |
| 2012 | 4 | 3 |
| 2011 | 3 | 3 |
| 2010 | 1 | 2 |
| 2009 | 2 | 1 |
| 2008 | 3 | 3 |
| 2006 | 2 | 2 |
Companies that share officeholders with Glaxosmithkline Australia Pty Ltd
People on the board of Glaxosmithkline Australia Pty Ltd also hold roles at 51 other companies. Those with the most shared officeholders are listed below.
| Company |
|---|
| Glaxo Wellcome Australia Pty Ltd Litigation alerts: hidden Watch |
| Wellcome Developments Pty Ltd Litigation alerts: hidden Watch |
| Wellcome Operations Pty Ltd Litigation alerts: hidden Watch |
| Glaxosmithkline Investments Pty Ltd Litigation alerts: hidden Watch |
| Glaxosmithkline Holdings Pty Ltd Litigation alerts: hidden Watch |
| Gsk Australia Nvd Pty Ltd Litigation alerts: hidden Watch |
| Stiefel Research (Australia) Holdings Pty Ltd Litigation alerts: hidden Watch |
| Stiefel Research Australia Pty Ltd Litigation alerts: hidden Watch |
| Haleon Australia Pty Ltd Litigation alerts: hidden Watch |
| Gsk Employee Share Plan Pty Ltd Litigation alerts: hidden Watch |
Watching Glaxosmithkline Australia Pty Ltd for litigation
Is Glaxosmithkline Australia Pty Ltd involved in a court case?
This page doesn't show court cases. Court and tribunal lists change every day, so the reliable way to know is to watch Glaxosmithkline Australia Pty Ltd: LitigationWatch checks every day and emails you as soon as it is named in a case.
How do I get alerts about Glaxosmithkline Australia Pty Ltd?
Choose Watch for litigation, pick a plan and confirm. Glaxosmithkline Australia Pty Ltd is added to your watchlist with its ACN and is included in the next daily check.
Which courts and tribunals are checked?
Courts and tribunals across every Australian jurisdiction: federal, state and territory. See coverage for details.
How much does it cost?
Standard is US$9 a month for up to 20 companies, and Pro is US$29 a month for up to 100. Cancel any time. Compare plans.